Apache Kafka, AWS, Azure, DevOps, Docker, Elasticsearch, JavaScript, R Programming, RNNs, UI design, UX design
Atomic AI, Inc. is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people.
The opportunity
As a full-time Senior Research Associate in the Bioscience team, you will work closely with scientists to advance our R&D technology platform for RNA structure prediction, target identification, and early drug discovery. You will perform structural and functional validation of novel RNA drug targets and support development of new methods to accelerate target discovery.
At Atomic AI, you will be an execution-focused self-starter with a passion for scientific research and a positive attitude when facing challenges. You will prioritize effectively amidst complexity, adapt nimbly to changing conditions, and grow outside of your comfort zone. You will collaborate thoughtfully and promote the success of all team members.
Primary responsibilities
About you
Pluses
Atomic AI is considering applicants at multiple levels for this role. Your level and salary will be based on your skills, knowledge and experience. Base salary is just one component of Atomic AI’s competitive total rewards strategy.
Salary Range: $95,000/year to $125,000/year + equity + benefits
Atomic AI is committed to equal employment opportunity regardless of race, color, ancestry, national origin, religion, sex, age, sexual orientation, gender identity and expression, marital status, disability, or veteran status.
Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure.